A Study to Assess Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Chinese Participants Receiving Upadacitinib for Atopic Dermatitis (AD) Through Chart Review
CompletedOBSERVATIONAL
Enrollment
150
Participants
Timeline
Start Date
August 6, 2024
Primary Completion Date
October 31, 2024
Study Completion Date
October 31, 2024
Conditions
Atopic Dermatitis (AD)
Trial Locations (1)
200040
Huashan Hospital affiliated to Fudan University /ID# 268259, Shanghai